China Self-Monitoring Blood Glucose Devices Market Share

Statistics for the 2023 & 2024 China Self-Monitoring Blood Glucose Devices market share, created by Mordor Intelligence™ Industry Reports. China Self-Monitoring Blood Glucose Devices share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of China Self-Monitoring Blood Glucose Devices Industry

The China Self-Monitoring Blood Glucose Devices Market is fragmented, with few significant and other generic players. Manufacturers like Abbott, LifeScan, Roche, and Ascensia, etc. occupy a major share.

China Self-Monitoring Blood Glucose Devices Market Leaders

  1. Roche Diabetes Care

  2. Abbott Diabetes Care

  3. LifeScan

  4. Arkray

  5. Sinocare

*Disclaimer: Major Players sorted in no particular order

China Self-Monitoring Blood Glucose Devices Market Concentration

China Self-Monitoring Blood Glucose Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2024 - 2029)